
|Videos|May 29, 2020
NCCN Recommendations: Frontline CLL Treatment Options
Advertisement
In this Directions in Oncology Pharmacy Insights video series, Alison Duffy, PharmD, BCOP, University of Maryland School of Pharmacy, and Cody Steeves, PharmD, BCOP, Biologics by McKesson, discuss advancements and updates in therapies for chronic lymphocytic leukemia (CLL). This first segment focuses on NCCN recommendations for frontline treatment options.
Newsletter
Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Pharmacy Times
1
Updates in Treatment of Unresectable Hepatocellular Carcinoma
2
FDA Approves Rucaparib for the Treatment of Adults With mCRPC
3
Notable Updates in Medication Therapy Management in 2025
4
Early Signals Before Myeloma: Real-World Data Reveal Missed Opportunities for Earlier Diagnosis
5












































































































































































































